The Sofia Influenza A+B Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral-flow technology to detect influenza A and influenza B viral nucleoprotein antigens. Features & Benefits:
This CLIA-waived test uses advanced immunofluorescence-based lateral-flow technology to detect influenza A and B viral nucleoprotein antigens in nasal and nasopharyngeal swab and nasopharyngeal aspirate/wash specimens taken directly from symptomatic patients.